Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Keratosis, Actinic 39Melanosis 3Carcinoma, Basal Cell 3Warts 1Keratosis, Seborrheic 1Keratosis 1Facies 1Condylomata Acuminata 1Carcinoma, Squamous Cell 1Carcinoma 1Bowen's Disease 1

Interventions

HhAntag691 18Imiquimod 10sonidegib 8Photochemotherapy 71-phenyl-3,3-dimethyltriazene 6methyl 5-aminolevulinate 4Surgical Procedures, Operative 4Biopsy 4Aminolevulinic Acid 4cemiplimab 3Mohs Surgery 3Microscopy, Confocal 3Itraconazole 3IPI-926 33-ingenyl angelate 3tazarotene 2Microarray Analysis 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2Drug Evaluation 2Acitretin 2tozuleristide 1teriflunomide 1talimogene laherparepvec 1silmitasertib 1remetinostat 1pembrolizumab 1gusacitinib 1green tea extract polyphenone E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Basal Cell × 3-ingenyl angelate × Clear all
NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed
24 enrolled
Dermatologic

Carcinoma, Carcinoma, Basal Cell

NCT00108121 2015-01-19

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma

Peplin

Phase 2 Completed
60 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00108134 2008-12-24

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

Peplin

Phase 2 Completed
60 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡